OakChart

Edwards Lifesciences Corp

EWHealthcare·Medical Devices·USA·Large·NYSE·Nov 11 • 3:59 PM ET

105.81+1.80 (1.73%)
2026-11-11 23:17 CET
Market cap
59,805.75 USD m
Revenue, TTM
6,674.70 USD m
Net income, TTM
994.30 USD m
Free cash flow, TTM
1,424.10 USD m
EPS diluted, TTM
1.72
P/E
61.62
Compare

Price

EW against its 20, 50 and 200-day averages
2050200miss
80.0090.00100.007.2M14.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26EWclose 105.8120-day 94.1350-day 89.78200-day 86.09105.81

0.2% under the 52-week high of 106.05 on 11 Nov 2026. 52-week low 74.66 on 11 Feb 2026. Last 15 sessions, 20.6% high to low

Volume 1.13× normal · the line is the 50-bar volume average

Profile

EW
52-week range, 100% of the way up
74.66105.37

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

IndexS&P 500, RUI
Employees16000
IPOMar 27, 2000
Beta0.81
ATR, 14d3.02
Rel volume1.13
Short float1.65%
Insider own1.22%
Inst own93.18%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap60.84B
Enterprise Value57.00B
Income994.30M
Sales6.67B
Book/sh18.87
Cash/sh8.08
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees16000
IPOMar 27, 2000

Ratios

P/E61.62
Forward P/E31.08
PEG2.15
P/S9.12
P/B5.61
P/C13.10
P/FCF42.72
EV/EBITDA26.99
EV/Sales8.54
Quick Ratio3.86
Current Ratio4.60
Debt/Eq0.06
LT Debt/Eq0.06
Option/ShortYes / Yes

Earnings

EPS (ttm)1.72
EPS next Y3.40
EPS next Q0.66
EPS this Y17.79%
EPS next Y12.91%
EPS next 5Y14.44%
EPS past 3/5Y-9.46% 6.79%
Sales past 3/5Y4.08% 6.70%
EPS Y/Y TTM-26.83%
Sales Y/Y TTM13.44%
EPS Q/Q6.39%
Sales Q/Q10.46%
EarningsNov 04 AMC
EPS/Sales Surpr.7.56% 2.10%

Ownership

Insider Own1.22%
Insider Trans-2.85%
Inst Own93.18%
Inst Trans2.05%
ROA7.25%
ROE9.44%
ROIC8.62%
Gross Margin78.30%
Oper. Margin29.07%
Profit Margin14.90%
SMA2012.40%
SMA5017.86%
SMA20022.91%
Trades-

Technical

Shs Outstand575.60M
Shs Float568.00M
Short Float1.65%
Short Ratio2.50
Short Interest9.38M
52W High105.37 0.42%
52W Low74.66 41.72%
Volatility3.62% 3.03%
ATR (14)3.02
RSI (14)78.86
Beta0.81
Rel Volume1.13
Avg Volume3.75M
Volume4,231,045

Performance

Perf Week6.48%
Perf Month24.09%
Perf Quarter14.32%
Perf Half Y30.00%
Perf YTD24.12%
Perf Year24.25%
Perf 3Y64.79%
Perf 5Y-7.44%
Perf 10Y248.79%
Recom1.55
Target Price115.29
Prev Close104.01
Price105.81
Change %1.73%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 05, 2026UpgradeRRobert W. BairdNeutral → Outperform$116+9.6%
Nov 04, 2026UpgradeTTruistHold → Buy$113+6.8%
Oct 07, 2026InitiatedBBarclaysOverweight$110+4.0%
Jul 28, 2026InitiatedUUBSBuy$110+4.0%
Jul 24, 2026UpgradeLLeerink PartnersMarket Perform → Outperform$101-4.5%
Apr 01, 2026UpgradeWWolfe ResearchPeer Perform → Outperform$92-13.1%
Jan 09, 2026UpgradeTTD CowenHold → Buy$97-8.3%
Dec 18, 2025UpgradeJJP MorganNeutral → Overweight$100-5.5%
Nov 03, 2025UpgradeRRaymond JamesMkt Perform → Outperform$96-9.3%
Oct 29, 2025UpgradeWWolfe ResearchUnderperform → Peer Perform

Peers

Mkt cap
TickerCompanyMkt cap
MDTMedtronic Plc129.98B
ABTAbbott Laboratories189.28B
BSXBoston Scientific Corp65.41B
AVRAnteris Technologies Global Corp604.46M
AORTArtivion Inc980.68M
PENPenumbra Inc12.68B
LIVNLivaNova PLC5.01B
TMDXTransmedics Group Inc3.20B
ATRCAtricure Inc2.93B
JNJJohnson & Johnson675.03B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Lippis Daniel J.CVP, TAVRNov 10 '26Option Exercise72.6861944,98940,653Nov 10 04:52 PM
Lippis Daniel J.CVP, TAVRNov 10 '26Sale104.2561964,53140,034Nov 10 04:52 PM
Lippis Daniel J.OfficerNov 10 '26Proposed Sale104.251,857193,592Nov 10 04:12 PM
Zovighian Bernard JCEONov 09 '26Option Exercise72.6823,1001,678,908121,945Nov 09 04:29 PM
Zovighian Bernard JCEONov 09 '26Sale103.0223,1002,379,77998,845Nov 09 04:29 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 09 '26Option Exercise72.6848,9003,554,05271,698Nov 09 04:29 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 09 '26Sale103.0548,9005,039,31122,798Nov 09 04:29 PM
Zovighian Bernard JOfficerNov 09 '26Proposed Sale103.0246,2004,759,559Nov 09 04:21 PM
BOBO DONALD E JROfficerNov 09 '26Proposed Sale103.0548,9005,039,313Nov 09 04:20 PM
Lippis Daniel J.CVP, TAVROct 08 '26Option Exercise72.6861944,98940,653Oct 08 05:24 PM
Lippis Daniel J.CVP, TAVROct 08 '26Sale85.6561953,01740,034Oct 08 05:24 PM
Lippis Daniel J.CVP, TAVRSep 11 '26Option Exercise72.6861944,98940,653Sep 11 07:15 PM
Lippis Daniel J.CVP, TAVRSep 11 '26Sale87.5161954,16940,034Sep 11 07:15 PM
Dahl Andrew M.SVP, Corporate ControllerAug 31 '26Sale91.0654449,53414,868Aug 31 05:47 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VOTVanguard Morningstar Mid-Cap Growth ETFAUM: 18.66B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.8000.7440.5301,7161,68019
2026Q22026-07-230.7800.7430.4191,7411,70023
2026Q12026-04-230.7800.7290.6561,6491,59726
2025Q42026-02-100.5800.6180.1101,5701,54728
2025Q32025-10-300.6700.5960.5001,5531,49827
2025Q22025-07-240.6700.6240.5741,5321,48826
2025Q12025-04-230.6400.5970.6211,4131,40126
2024Q42025-02-110.5900.5510.6531,3861,35927
2024Q32024-10-240.6700.665-0.3841,3541,54420
2024Q22024-07-240.7000.6940.6061,6321,65328
2024Q12024-04-250.6600.6430.5831,5981,57026
2023Q42024-02-060.6400.6370.6101,5341,49727
2023Q32023-10-250.5900.5930.6321,4811,48027
2023Q22023-07-260.6600.6480.5031,5301,50525
2023Q12023-04-260.6200.6080.5571,4601,39425
2022Q42023-01-310.6400.6160.6471,3481,33423

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.8571.8681.6454,3484,320
2020FY1.8601.8891.3034,3864,385
2021FY2.2202.2632.3815,2335,259
2022FY2.4802.4602.4385,3825,369
2023FY2.5102.5092.3016,0055,970
2024FY2.4302.5681.4595,4405,795
2025FY2.5602.5951.8106,0686,044
2026FY-3.015--6,813
2027FY-3.405--7,494
2028FY-3.837--8,242
2029FY-4.252--9,040
2030FY-4.695--9,848

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0924401,7091,6971,728
2026Q4S2026-11-0524401,7091,6971,728
2026Q4S2026-11-0415111,7061,6881,725
2026Q4S2026-11-0316011,7031,6731,724
2026Q4S2026-11-0215011,7031,6731,724
2026Q4S2026-11-0115101,7051,6731,724
2026Q4S2026-10-2625101,7021,6731,724
2026Q4S2026-10-1425101,7011,6731,724
2026Q4S2026-10-0925101,7011,6731,724
2026Q4S2026-10-0725101,7011,6731,724
2026Q4S2026-09-3025191,7011,6731,724
2026Q4S2026-09-2925191,7011,6731,724
2026Q4S2026-09-10250101,7011,6731,724
2026Q4S2026-07-3125191,7011,6731,724

Estimate history

EPS, annual0.91.1271.6451.3032.3812.4382.3011.4591.811.7171
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.3840.6530.6210.5740.50.110.6560.4190.532
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual3435.33722.843484386.35232.55382.450105439.56067.66674.7
Period201720182019202020212022202320242025TTM
Sales, quarterly1354.41385.81412.71532.21553.11569.61648.617411715.5
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual629.101623.101627.301624.3624.1608.3601.1588.6580.7575.6
Period201720182019202020212022202320242025MRQ
Shares, quarterly589.8588.6586.2587.9580.7580.7577576.6575.6
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue6,674.706,067.605,439.505,010.005,382.405,232.504,386.304,348.003,722.80
Cost of Goods Sold Incl. D&A1,448.401,340.101,153.301,037.301,167.201,225.901,099.001,155.30922.10
Gross Profit5,226.304,727.504,286.203,972.704,215.204,006.603,287.303,192.702,800.70
Selling, General and Administrative Excl. Other3,338.503,164.402,842.202,545.402,512.802,396.201,991.301,994.801,708.40
Research and Development1,091.301,079.201,053.00962.90945.20903.10760.70752.70622.20
Other Operating Expense-52.80-67.20-0.300.000.000.000.000.000.00
Operating Income1,940.601,630.301,444.301,427.301,702.401,610.401,296.001,197.901,092.30
Interest Expense-20.4019.8017.6026.2024.8022.2027.3033.40
Unusual Expense668.10512.5041.60163.40-1.60-130.90435.5092.20313.70
Net Income Before Taxes1,432.401,272.901,548.101,372.401,767.401,702.00916.701,166.50761.40
Income Taxes444.70216.90152.10152.40245.50198.9093.30119.6039.20
Consolidated Net Income987.701,056.001,396.001,220.001,521.901,503.10823.401,046.90722.20
Net Income From Continuing Operations994.301,060.101,400.901,223.001,521.901,503.10823.401,046.90722.20
Net Income994.301,060.10874.601,402.401,521.901,503.10823.401,046.90722.20
EPS (Recurring)2.532.421.512.492.442.241.791.751.47
EPS (Basic, Before Extraordinaries)1.721.811.462.312.462.411.321.681.15
EPS (Diluted)1.721.811.462.302.442.381.301.641.13
EBITDA2,111.801,786.901,599.501,572.201,869.201,773.701,431.401,312.501,169.70
Non-Operating Income (Expense)159.90175.50165.20126.1089.60-14.5078.4088.1016.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense134.14129.90120.80103.00105.2090.4077.2059.3556.09
Price To Earnings Ratio60.5760.5710.6832.6032.1254.3970.3147.2945.45
Price To Sales Ratio7.478.238.169.278.6515.6313.1411.398.79
Gross Margin78.3077.9178.8079.3078.3176.5774.9473.4375.23
Operating Margin29.0726.8726.5528.4931.6330.7829.5527.5529.34
Net Margin14.9017.4716.0827.9928.2828.7318.7724.0819.40
Shares Outstanding575.60580.70588.60601.10608.30624.10624.30627.30623.10
Market Capitalization59,805.7559,805.7543,662.8946,245.6246,128.3880,882.6056,858.9248,780.9931,813.44

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,715.501,741.001,648.601,569.601,553.101,532.201,412.701,385.80
Cost of Goods Sold Incl. D&A371.00381.50360.10335.80337.20355.30311.80296.10
Gross Profit1,344.501,359.501,288.501,233.801,215.901,176.901,100.901,089.70
Selling, General and Administrative Excl. Other842.30840.10785.50870.60795.30778.20720.30763.00
Research and Development281.40278.90263.30267.70280.70276.20254.60271.10
Other Operating Expense-13.30-11.00-14.20-14.30-12.50-21.30-19.10-22.70
Operating Income515.50530.40517.20377.50433.10420.00399.70349.40
Unusual Expense216.5046.6096.10308.90117.2060.0026.4040.70
Net Income Before Taxes363.20519.80459.0090.40348.40400.20433.90390.10
Income Taxes61.80278.4078.3026.2056.1064.3070.3045.10
Consolidated Net Income301.40241.40380.7064.20292.30335.90363.60345.00
Net Income From Continuing Operations307.50241.90380.7064.20293.10337.60365.20346.30
Net Income307.50241.90380.7064.20293.10337.60365.20385.60
EPS (Recurring)0.790.480.770.480.640.650.650.70
EPS (Basic, Before Extraordinaries)0.530.420.660.110.500.580.620.65
EPS (Diluted)0.530.420.660.110.500.570.620.65
EBITDA560.40573.10558.10420.20472.30458.10436.30392.00
Non-Operating Income (Expense)64.2036.0037.9021.8032.5040.2060.6081.40
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense37.4035.2029.9431.6033.3031.4033.6026.80
Price To Earnings Ratio60.5749.1544.3336.2953.0952.2529.5910.68
Price To Sales Ratio7.478.027.388.177.748.097.697.64
Gross Margin78.3778.0978.1678.6178.2976.8177.9378.63
Operating Margin30.0530.4731.3724.0527.8927.4128.2925.21
Net Margin17.9213.8923.094.0918.8722.0325.8527.83
Shares Outstanding575.60576.60577.00580.70580.70587.90586.20588.60
Market Capitalization59,805.7552,086.8746,510.4649,470.5745,658.7745,877.9942,455.5243,662.89

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments4,226.803,979.101,636.101,215.801,468.301,402.601,516.90956.501,337.50
Short Term Receivables912.10727.40828.10699.10664.90602.80599.10537.30479.30
Inventories1,126.201,086.70903.50875.50726.70802.30640.90607.00554.90
Other Current Assets473.80492.20668.00305.40320.80283.30227.10186.10177.50
Total Current Assets6,738.906,285.404,035.703,095.803,180.703,091.002,984.002,286.902,549.20
Net Property, Plant & Equipment1,914.601,784.201,675.401,725.101,638.701,489.401,140.40867.50679.70
Total Investments and Advances285.40343.40608.001,282.701,856.40801.60585.50506.30567.00
Long-Term Note Receivable488.50--------
Intangible Assets2,896.802,953.301,544.501,449.501,491.501,504.601,504.201,455.401,594.50
Deferred Tax Assets1,138.10992.10749.40484.00246.70230.90172.20174.00167.10
Other Assets234.90696.90750.20255.4088.60119.60101.8033.60108.90
Total Assets13,697.2013,055.309,363.208,292.508,502.607,237.106,488.105,323.705,666.40
Short Term Debt Incl. Current Port. of LT Debt24.5023.4022.9025.5025.5027.2025.500.00598.00
Accounts Payable227.50197.40186.60201.90204.50196.50180.40134.00116.60
Income Tax Payable192.50286.6052.7050.6030.6018.6052.9031.3097.80
Other Current Liabilities1,369.20997.80933.20744.40771.70651.60643.60711.30607.60
Total Current Liabilities1,813.701,505.201,195.401,022.401,032.30893.90902.40876.601,420.00
Long Term Debt680.90676.60662.20665.80664.80667.70653.30593.80438.40
Provision for Risks Charges502.70437.30429.20410.50450.30447.40171.70124.90164.60
Other Liabilities362.30373.30357.00387.10519.30653.80612.40588.00687.20
Total Liabilities3,359.602,992.402,643.802,485.802,666.702,662.802,339.802,183.302,710.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity10,337.609,998.406,650.005,806.705,835.904,574.304,148.303,140.402,956.20
Total Shareholders Equity10,337.609,998.406,650.005,806.705,835.904,574.304,148.303,140.402,956.20
Accumulated Minority Interest0.0064.5069.400.000.000.000.000.000.00
Total Equity10,337.6010,062.906,719.405,806.705,835.904,574.304,148.303,140.402,956.20
Total Liabilities & Stockholders Equity13,697.2013,055.309,363.208,292.508,502.607,237.106,488.105,323.705,666.40
Book Value Per Share17.8016.9911.069.559.357.336.615.044.70
Tangible Book Value Per Share12.8111.978.497.166.964.924.222.702.16
Full-Time Employees16,00015,80019,80017,30015,70014,90013,90012,80012,200
Price to Book Ratio5.514.576.957.4313.8512.4511.7610.137.54
Return on Assets7.9312.5013.8518.1219.1012.0017.7313.1111.47
Return on Equity10.4316.8319.6426.1428.8818.8828.7323.6920.94
Return on Invested Capital9.628.1919.1823.5123.1215.7121.8019.3417.19
Quick Ratio3.093.452.622.172.382.562.601.921.40
Current Ratio3.724.183.383.033.083.463.312.611.80

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,014.701,069.404,169.701,399.401,521.901,503.10823.401,046.90722.20
Depreciation171.20156.60155.20144.90166.80163.30135.40114.6077.40
Other Funds (Non Cash)536.30332.20-3,199.90149.90205.40-38.20102.70210.10197.10
Funds from Operations1,797.901,440.60801.601,422.101,639.601,586.801,012.101,383.70969.40
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-81.00154.60-259.30-526.30-421.40145.3042.20-204.30-42.60
Income Taxes Payable155.30-141.80-186.70-5.80-5.6062.00-52.9043.20-157.80
Cash from Operating Activities1,716.901,595.20542.30895.801,218.201,732.101,054.301,179.40926.80
Capital Expenditures-292.80-260.20-282.40-266.30-264.80-329.80-407.30-278.40-241.70
Net Assets From Acquisitions-33.70-233.70-1,061.80-95.200.00-13.10-10.00-135.200.00
Sale of Fixed Assets and Businesses78.8078.803,927.400.000.000.000.000.00-
Purchase or Sale of Investments-371.90-321.80-88.20640.30689.80-1,350.10-74.70-158.20323.20
Purchase of Investments-2,750.00-3,199.90-945.80-75.50-669.30-1,879.30-851.70-568.10-478.50
Sale Or Maturity of Investments2,378.102,878.10857.60715.801,359.10529.20777.00409.90801.70
Other Uses-121.10-209.70-182.10-105.00-190.70-49.50-39.10-24.00-10.00
Other Sources0.000.000.000.0018.0020.00--5.20
Cash from Investing Activities-740.70-946.602,312.90173.80252.30-1,722.50-531.10-595.8076.70
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-563.10-719.30-979.90-709.70-1,580.70-354.20-484.90-102.80-648.50
Repurchase of Common Pref Stock-754.60-893.40-1,159.40-879.60-1,727.10-512.80-625.40-263.30-795.50
Sale of Common Pref Stock191.50174.10179.50169.90146.40158.60140.50160.50147.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.00-0.20-1.80-0.80-10.00-437.30
Change in Long Term Debt0.000.000.000.00-0.20-1.80-0.80-10.00-437.30
Issuance of Long Term Debt0.000.000.000.000.005.2016.2018.90688.00
Reduction of Long Term Debt0.000.000.000.00-0.20-7.00-17.00-28.90-1,125.30
Net Financing Active Other Cash Flow-0.60-3.80-3.10-1.30-3.60-0.30-1.20-2.80-15.40
Other Financing Activities Uses-3.10-3.80-3.10-1.30-3.60-0.30-1.20-2.80-15.40
Cash from Financing Activities-563.70-723.10-983.00-711.00-1,584.50-356.30-486.90-115.60-1,101.20
Exchange Rate Effect5.10-44.8038.6016.8019.2013.90-20.50-3.00-6.50
Net Change in Cash417.60-119.301,910.80375.40-94.80-332.8015.80465.00-104.20
Free Cash Flow1,424.101,335.00289.90642.80973.601,406.30647.30925.00688.10
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow35.0137.41153.0472.2947.8358.1589.0653.5247.55
Deferred Taxes & Investment Tax Credit--117.60-323.40-272.10-254.50-41.40-49.4012.10-27.30

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments4,645.604,255.103,672.504,226.803,842.704,063.40
Short Term Receivables937.80955.70973.00912.10892.80902.60
Inventories1,159.401,131.201,119.001,126.201,140.901,141.70
Other Current Assets504.70476.90464.20473.80482.50469.50
Total Current Assets7,247.506,818.906,228.706,738.906,358.906,577.20
Net Property, Plant & Equipment1,958.501,942.101,922.401,914.601,839.801,825.60
Total Investments and Advances278.10259.50300.80285.40280.80302.60
Intangible Assets3,112.803,333.803,047.502,896.802,899.302,949.50
Deferred Tax Assets929.40911.801,098.101,138.101,099.901,082.10
Other Assets132.10120.10186.40234.90262.30248.30
Total Assets14,144.4013,867.1013,321.2013,697.2013,272.2013,488.70
Short Term Debt Incl. Current Port. of LT Debt24.9024.1024.3024.5026.8025.90
Accounts Payable199.70210.50181.10227.50165.00162.10
Income Tax Payable191.40192.90204.90192.50129.50146.30
Other Current Liabilities1,160.701,080.40998.701,369.201,266.701,070.40
Total Current Liabilities1,576.701,507.901,409.001,813.701,588.001,404.70
Long Term Debt679.60680.30678.60680.90673.50676.70
Provision for Risks Charges580.30572.20555.40502.70442.90421.60
Other Liabilities346.30381.80350.70362.30362.80379.20
Total Liabilities3,182.903,142.202,993.703,359.603,067.202,882.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity10,861.1010,618.0010,327.5010,337.6010,205.0010,545.30
Total Shareholders Equity10,861.1010,618.0010,327.5010,337.6010,205.0010,545.30
Accumulated Minority Interest100.40106.900.000.000.0061.20
Total Equity10,961.5010,724.9010,327.5010,337.6010,205.0010,606.50
Total Liabilities & Stockholders Equity14,144.4013,867.1013,321.2013,697.2013,272.2013,488.70
Book Value Per Share18.8718.4117.9017.8017.5717.94
Tangible Book Value Per Share13.4612.6312.6212.8112.5812.92
Full-Time Employees---16,000--
Price to Book Ratio5.515.054.504.854.344.53
Return on Assets7.257.168.177.9310.2311.98
Return on Equity9.449.2610.5210.4313.5915.71
Return on Invested Capital2.662.143.460.582.693.01
Quick Ratio3.863.773.633.093.293.87
Current Ratio4.604.524.423.724.004.68

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income301.40241.40380.7091.20290.30331.50
Depreciation44.9042.7040.9042.7039.2038.10
Other Funds (Non Cash)250.3054.60114.30117.1069.5083.20
Funds from Operations536.00520.00545.30196.60381.00431.90
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital34.30131.90-501.50254.30192.70-141.70
Income Taxes Payable43.8012.0041.9057.60-10.20-240.40
Cash from Operating Activities570.30651.9043.80450.90573.70290.20
Capital Expenditures-63.60-66.90-64.90-97.40-57.50-49.30
Net Assets From Acquisitions0.001.40-35.100.00-233.700.00
Sale of Fixed Assets and Businesses0.000.000.0078.800.000.00
Purchase or Sale of Investments-184.70-122.7062.70-127.20-340.40-52.50
Purchase of Investments-677.20-571.20-659.90-841.70-1,032.30-678.60
Sale Or Maturity of Investments492.50448.50722.60714.50691.90626.10
Other Uses-8.10-5.00-55.50-52.50-29.90-70.20
Other Sources0.000.000.000.000.00-0.10
Cash from Investing Activities-256.40-193.20-92.80-198.30-661.50-172.10
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-102.400.50-452.90-8.30-504.0051.70
Repurchase of Common Pref Stock-138.90-53.30-521.80-40.60-538.70-5.50
Sale of Common Pref Stock36.5053.8068.9032.3034.7057.20
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow1.60-0.801.70-3.10-2.401.00
Other Financing Activities Uses0.000.000.00-3.10-0.700.00
Cash from Financing Activities-100.80-0.30-451.20-11.40-506.4052.70
Exchange Rate Effect-10.403.808.203.50-1.00-29.60
Net Change in Cash202.70462.20-492.00244.70-595.20141.20
Free Cash Flow506.70585.00-21.10353.50516.20240.90
Price to Free Cash Flow35.0136.4542.6837.1556.6478.21

Revenue breakdown

Surgical Heart Valve Therapy2024: 981.30M 2025: 1.03B
Transcatheter Aortic Valve Replacement2024: 4.11B 2025: 4.49B
Transcatheter Mitral And Tricuspid Therapies2024: 352.10M 2025: 550.60M
Europe2024: 1.32B 2025: 1.52B
Japan2024: 339.80M 2025: 354.70M
Other countries2024: 572.00M 2025: 652.30M
United States2024: 3.21B 2025: 3.54B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.65%9.4M568.0M3.35M
2026-10-151.64%9.3M569.4M3.77M
2026-09-301.68%9.5M569.4M3.88M
2026-09-151.60%9.1M569.4M4.13M
2026-08-311.58%9.0M569.4M4.46M
2026-08-141.80%10.2M569.4M4.86M
2026-07-311.77%10.0M568.4M5.05M
2026-07-152.00%11.4M568.4M5.16M
2026-06-302.02%11.5M568.5M5.18M
2026-06-152.08%11.8M568.2M5.01M
2026-05-292.14%12.2M568.5M5.03M
2026-05-152.00%11.4M568.5M4.94M
2026-04-301.86%10.5M568.0M5.23M
2026-04-151.64%9.3M568.8M4.74M
2026-03-311.74%10.0M572.7M4.60M
2026-03-131.91%10.9M572.7M4.30M
2026-02-272.16%12.4M572.7M3.91M
2026-02-131.38%7.9M572.2M3.82M
2026-01-301.41%8.1M572.4M3.56M
2026-01-151.38%7.9M572.4M3.96M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call40.0064.5067.200.004.2970.000.000.992-0.0650.004
call42.5062.1064.800.004.1270.000.000.991-0.0650.004
call45.0059.6062.200.003.8300.000.000.991-0.0640.004
call47.5057.1059.7035.173.6161.000.000.990-0.0640.004
call50.0054.6057.300.003.4750.000.000.989-0.0640.005
call55.0049.6052.3028.073.0951.000.000.988-0.0640.005
call60.0044.6047.3033.082.7471.000.000.987-0.0630.006
call65.0039.6042.300.002.4260.000.000.985-0.0620.006
call70.0034.6037.4029.802.1687.000.000.982-0.0620.007
call72.5032.1034.2020.301.7181.000.000.981-0.0610.008
call75.0029.6032.1029.991.76712.000.000.979-0.0600.008
call77.5027.1029.2010.701.4707.000.000.978-0.0600.009
call80.0024.6026.5020.001.25911.000.000.976-0.0590.009
call82.5022.1024.109.451.19120.000.000.973-0.0580.010
call85.0019.6021.9017.451.19095.000.000.971-0.0570.011
call87.5017.1019.1013.530.8411900.000.967-0.0560.012
call90.0014.6016.3014.700.7412,8032960.963-0.0550.013
call92.5012.1014.6012.150.8932,1891.000.958-0.0530.015
call95.0010.1012.1011.150.7722,36833.000.951-0.0510.017
call97.507.5010.307.380.7966,5191,9420.906-0.0750.028
call1005.507.405.500.5842,12013.000.832-0.1020.041
call1051.952.552.190.3151,75618.000.581-0.1190.064
call1100.200.550.510.3013,23574.000.261-0.1130.053
call1150.000.350.110.41814633.000.119-0.0820.033
call1200.002.200.540.56612.000.000.085-0.0830.026
call1250.002.350.550.70015.000.000.071-0.0900.022
call1300.002.350.350.82411.000.000.062-0.0950.020
call1350.002.350.300.9394.000.000.056-0.1000.019
call1400.002.100.301.1232.000.000.061-0.1240.020
put40.000.002.150.303.6315.000.00-0.025-0.1920.010
put42.500.002.150.453.4234.000.00-0.027-0.1900.010
put45.000.002.150.753.2273.000.00-0.028-0.1890.011
put47.500.003.100.752.4051.000.00-0.010-0.0590.004
put50.000.002.550.252.2644.000.00-0.011-0.0590.005
put55.000.002.551.472.00110.000.00-0.012-0.0580.005
put60.000.002.550.451.7606.000.00-0.013-0.0560.006
put65.000.000.350.151.6882570.00-0.026-0.0930.010
put70.000.001.950.821.32332.000.00-0.018-0.0530.007
put72.500.001.550.021.2312290.00-0.019-0.0530.008
put75.000.002.600.091.1351500.00-0.021-0.0520.008
put77.500.001.200.821.0413,8490.00-0.022-0.0510.009
put80.000.003.100.100.9503510.00-0.024-0.0500.009
put82.500.003.100.100.8608720.00-0.027-0.0490.010
put85.000.002.350.050.7722,9670.00-0.029-0.0480.011
put87.500.002.150.180.6861520.00-0.033-0.0460.012
put90.000.002.200.050.6003120.00-0.037-0.0450.013
put92.500.001.400.280.5162780.00-0.042-0.0430.015
put95.000.000.150.100.4323252.00-0.049-0.0400.017
put97.500.050.200.150.37169.008.00-0.094-0.0640.028
put1000.200.400.360.3456851.00-0.168-0.0910.041
put1050.951.551.250.30216.006.00-0.419-0.1070.064
put1103.605.800.000.5040.000.00-0.739-0.1010.053
put1158.0010.500.000.6730.000.00-0.881-0.0690.033
put12013.1015.400.000.8390.000.00-0.915-0.0700.026
put12518.0020.500.001.0300.000.00-0.929-0.0760.022
put13023.3025.500.001.1830.000.00-0.938-0.0810.020
put13528.5030.500.001.3250.000.00-0.944-0.0850.019
put14033.5035.500.001.4580.000.00-0.949-0.0880.017

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-10SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-13SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-08-31144Filing for proposed sale of securities under Rule 144.SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-31SEC
2026-08-28144Filing for proposed sale of securities under Rule 144.SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-288-KCurrent report2026-08-25SEC
2026-08-26144Filing for proposed sale of securities under Rule 144.SEC
2026-08-26144Filing for proposed sale of securities under Rule 144.SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-04S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-30144Filing for proposed sale of securities under Rule 144.SEC
2026-07-30144Filing for proposed sale of securities under Rule 144.SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-28144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11007.48M3
2026-100053.02K1
2026-090054.17K1
2026-08003.35M5
2026-07001.13M4
2026-0600102.56K2
2026-05006.75M10
2026-04002.94M3
2026-03002.17M3
2026-02003.73M2
2026-01001.06M2
2025-12005.23M9
2025-11001.16M2

Institutional holders

Manager% owned
BlackRock, Inc.10.21%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
VANGUARD PORTFOLIO MANAGEMENT LLC4.59%
STATE STREET CORP4.57%
JPMORGAN CHASE & CO3.96%
WELLINGTON MANAGEMENT GROUP LLP2.92%
GEODE CAPITAL MANAGEMENT, LLC2.71%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main2.26%
Ninety One UK Ltd2.07%
Bank of New York Mellon Corp1.96%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
Baird Aggregate Bond Fund3.13%
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND2.97%
Baird Short-Term Bond Fund2.61%
VANGUARD 500 INDEX FUND2.59%
VANGUARD MID-CAP INDEX FUND2.17%
Baird Core Plus Bond Fund2.10%
VANGUARD HEALTH CARE FUND1.97%
VANGUARD TOTAL BOND MARKET INDEX FUND1.54%
iShares Core S&P 500 ETF1.38%

OakChart. EW. Cached 15 minutes.